Project Grant HT94252410465
Award Date
6/1/24
Completion Date
5/31/27
Dollars Obligated
$727K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94103, USA
Similar Awards
The Regents of the University of California, San Francisco (UCSF) has been awarded a $499,985 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a 2-year research project titled "DIET, EXERCISE, AND INFLAMMATION IN EARLY-STAGE NEURONAL ALPHA-SYNUCLEIN DISEASE" to investigate novel approaches for treating neurodegenerative disorders relevant to military personnel and the broader population. As a...
This Project Grant award of $1,008,313.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research initiatives at the University of California, San Francisco (UCSF). The funding will enable UCSF to conduct innovative research focused on transforming healthcare for military service members and the broader public, with a particular emphasis on addressing critical medical challenges such as cancer,...
This federal Project Grant award of $997,060 from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports research at the University of California, San Francisco (UCSF) to develop a new understanding of selective neuron vulnerability and neuroprotection in progressive multiple sclerosis. The award has a performance period from September 15, 2024 to September 14, 2027. As a leading academic medical center and research institution, UCSF will leverage...
The University of California, San Francisco (UCSF) has been awarded a $726,750 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). This 3-year federal grant, with a period of performance from June 2024 to June 2027, will support research to elucidate the role of ERα RNA binding activity in breast cancer progression and drug-tolerant persister cells. As a leading academic medical center with extensive experience in federally...
The Defense Health Agency (DHA) awarded a $963,110 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "SAFETY OF TRANSCUTANEOUS ELECTRICAL STIMULATION POTENTIATING RECOVERY IN ACUTE SPINAL CORD INJURY SYNDROMES (STEP-RAISE)", will fund research focused on exploring innovative approaches to the safety and efficacy of transcutaneous electrical...
The Defense Health Agency awarded a $1,453,500.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, commencing on June 20, 2023, will support UCSF's research to profile and eliminate tumor subclones resistant to radioligand therapy. Through this project, UCSF aims to transform health care for Service Members and the American public by developing innovative and...
This federal Project Grant award, valued at $993,283.00, was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The grant supports biomedical research focused on advancing understanding of multiple sclerosis progression, to be conducted by the University of California, San Francisco (UCSF) over a period from September 1, 2025 to August 31, 2027. The research aims to identify proteomic determinants and components that drive the...
The University of California, San Francisco (UCSF) has been awarded a $1,202,087 federal Project Grant from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to investigate SSTR1 as a novel biomarker and therapeutic target in advanced prostate cancer. The award, effective July 1, 2024 through June 30, 2028, will enable UCSF researchers to conduct innovative scientific studies to develop new treatments for this challenging disease. As a leading academic...
The Defense Health Agency awarded a $656,000.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant will fund research to investigate the role of myeloid cells and other inflammatory components in the progression of Barrett's esophagus to invasive esophageal adenocarcinoma over a 2-year performance period from May 2025 to May 2027. As a leading academic medical...
This $300,000 Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco (UCSF). The award is intended to support research focused on "Identifying Regulators of Extrafollicular Plasma Cell Differentiation" over the July 2024 to July 2026 performance period. As a leading academic medical center, UCSF will leverage its expertise in biomedical research...